Cancer BiologyCancersPeer-reviewed
AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis
Siobhan K. McRee, Abraham L. Bayer, Jodie R. Pietruska…·Philip W. Hinds
This study shows AKT2 promotes melanoma metastasis while AKT1 is critical for tumor initiation, suggesting AKT2 as a therapeutic target in BRAF-mutant melanoma.